Perioperative nivolumab results in favourable long-term outcomes in patients with locally advanced resectable non-small-cell lung cancer

被引：0

作者：

Cascone, Tina ^{[1
]}

William Jr, William N. ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA

[2] Grp Oncoclin, Sao Paulo, Brazil

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2025年 / 22卷 / 02期

关键词：

D O I：

10.1038/s41571-024-00976-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

As one of the first studies testing perioperative anti-PD-(L)1 antibodies in resectable non-small- cell lung cancer (NSCLC), NADIM now confirms, in its final report, impressive 5-year clinical outcomes and that a pCR following neoadjuvant therapy translates into improved long-term survival. These data support the development of novel, personalized treatments for locally advanced resectable NSCLC.

引用

页码：81 / 82

页数：2

共 50 条

[1] Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer
Spina, R.
Chu, S. Y. Y.
Chatfield, M.
Chen, J.
Tin, M. M.
Boyer, M.
INTERNAL MEDICINE JOURNAL, 2013, 43 (07) : 790 - 797
[2] Long-term results of combined-modality therapy in resectable non-small-cell lung cancer
Martin, J
Ginsberg, RJ
Venkatraman, ES
Bains, MS
Downey, RJ
Korst, RJ
Kris, MG
Rusch, VW
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) : 1989 - 1995
[3] Long-term outcomes with nivolumab in patients with previously treated advanced Non-Small Cell Lung Cancer (NSCLC)
Thomas, M.
Kohlhaeufl, M.
Reck, M.
Engel-Riedel, W.
Kortsik, C.
Bullinger, L.
Schneider, C. -P.
Felip, E.
Brahmer, J.
Vokes, E.
Gettinger, S.
Geese, W.
Yoon, D.
Healey, D.
Li, A.
Eberhardt, W. E. E.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 137 - 137
[4] Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
Horita, Nobuyuki
Fujiwara, Yu
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (03): : 287 - 288
[5] Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer
Heymach, John V.
Harpole, David
Mitsudomi, Tetsuya
Taube, Janis M.
Galffy, Gabriella
Hochmair, Maximilian
Winder, Thomas
Zukov, Ruslan
Garbaos, Gabriel
Gao, Shugeng
Kuroda, Hiroaki
Ostoros, Gyula
Tran, Tho V.
You, Jian
Lee, Kang-Yun
Antonuzzo, Lorenzo
Papai-Szekely, Zsolt
Akamatsu, Hiroaki
Biswas, Bivas
Spira, Alexander
Crawford, Jeffrey
Le, Ha T.
Aperghis, Mike
Doherty, Gary J.
Mann, Helen
Fouad, Tamer M.
Reck, Martin
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (18): : 1672 - 1684
[6] Perioperative immunotherapy for resectable non-small-cell lung cancer
Xiaodong Yang
Dongliang Bian
Jie Yang
Liang Duan
Haifeng Wang
Deping Zhao
Gening Jiang
Yuming Zhu
Peng Zhang
Clinical Cancer Bulletin, 3 (1):
[7] Perioperative Nivolumab and Chemotherapy in Non-Small-Cell Lung Cancer
Verma, Saurav
Vincent, Mark
Breadner, Daniel
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (16): : 1534 - 1534
[8] LONG-TERM RESULTS OF NEOADJUVANT IFOSFAMIDE, CISPLATIN, AND ETOPOSIDE COMBINATION IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER
PUJOL, JL
HAYOT, M
ROUANET, P
LECHEVALIER, T
MICHEL, FB
CHEST, 1994, 106 (05) : 1451 - 1455
[9] Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer
Yun, Jae Kwang
Bok, Jin San
Lee, Geun Dong
Kim, Hyeong Ryul
Kim, Yong-Hee
Kim, Dong Kwan
Park, Seung-Il
Choi, Sehoon
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 58 (01) : 59 - 69
[10] Long-term results in patients with pathological complete response after induction radiochemotherapy followed by surgery for locally advanced non-small-cell lung cancer†
Lococo, Filippo
Cesario, Alfredo
Margaritora, Stefano
Dall'Armi, Valentina
Mattei, Francesca
Romano, Rosalia
Porziella, Venanzio
Granone, Pierluigi
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 43 (03) : E71 - E81

← 1 2 3 4 5 →